🚀 July 3, 2026 Stock Price Gainers Ranking Top 10 Report & News Information
📊 1. Market Summary and Today's Sentiment
Number of advancing stocks: Over 70% of the Tokyo Stock Exchange Prime Market (1,222 stocks) rose (289 stocks declined)
Exchange rate (as of evening): 1 dollar = high 160 yen range (dollar appreciation paused ahead of US employment statistics, etc., with some buying back toward a stronger yen)
Key Points
Dramatic V-shaped recovery from a morning drop of over 1,100 yen Lingering caution regarding the previous day's decline in US tech stocks and reports of Apple's semiconductor procurement in China led to a sharp drop of over 1,100 yen in the morning, briefly falling well below the psychological threshold of 68,000 yen (low of 67,609.49 yen). However, abundant standby funds, mainly from overseas investors, flowed in at once, causing the market to pull back from the lows and rapidly emerge into positive territory.
Kioxia HD's sharp rebound and the sense of security from a broad-based rally Kioxia Holdings, which had briefly plunged nearly 12% the previous day, saw a fierce rebound of 9.2% due to persistent earnings expectations, which invited a sense of security to the market. Fast Retailing and Advantest, which have high index contributions, also significantly drove the market, and all 33 major industry sectors rose in a broad-based rally, with funds circulating widely from value stocks to tech stocks.
🔍 2. Gainers Ranking Stock Data (SBI Securities 1st to 10th place)
1st Place: Kubota Pharmaceutical Holdings (4596, TSE Growth)
【Business Description】
A drug discovery venture developing biopharmaceuticals specialized in ophthalmic diseases. It focuses on the research and development of therapeutic drugs and medical devices for retinal degenerative diseases, myopia, and glaucoma.
【Reason for Rise】
Announced the receipt of milestone payments related to the manufacturing of emixustat hydrochloride. Viewed as a positive factor with expectations for contribution to earnings, it was bought up to the daily limit high.
【Related News】
(2026/07/03) Following the previous day's positive disclosure, it saw buying interest from the morning and recorded a daily limit high, surging to 1st place in the gainers ranking.
(2026/07/02) Announced the receipt of milestone payments related to the manufacturing of the Stargardt disease treatment candidate drug 'emixustat hydrochloride.' With the steady progress of development confirmed, expectations for future earnings contributions rose sharply.
#KubotaPharmaceuticalHoldings #Biopharmaceuticals #StargardtDisease #DailyLimitHigh
2nd Place: Kaiho (3133, TSE Growth)
【Business Description】
Operates a nationwide chain of restaurants such as izakayas. In recent years, it has been entering and strengthening renewable energy-related businesses (such as solar power generation) as a pillar for management restructuring and new business.
【Reason for Rise】
Although the stock price had adjusted (stagnated) significantly due to factors such as the recent abolition of shareholder benefits, today it is showing a sharp rebound movement involving autonomous recovery from the feeling that selling has run its course, as well as short-term buybacks.
【Related News】
(2026/07/03) It showed a sharp rebound from the recent significant decline, surging +41.67% compared to the previous day.
(2026/06/26) Timely disclosure of supplementary materials regarding the financial statements for the fiscal year ended March 2026, for which an 'opinion was not expressed.' Buying aimed at an autonomous rebound has flowed in as selling due to governance and uncertainty has run its course and the deterioration in supply and demand has eased.
#Kaiho #Restaurants #RenewableEnergy #AutonomousRebound
3rd Place: ReYuu Japan (9425, TSE Standard)
【Business Description】
Develops sales of reused smartphones and used mobile phones, as well as rental businesses. A consolidated subsidiary of Showcase (3909).
【Reason for Rise】
Announced the acquisition of all shares of 'Ai Pro,' which handles smartphone repair businesses, making it a subsidiary. Buying flooded in due to expectations for business expansion.
[Related News]
(2026/07/02) Announced the signing of a basic agreement for the full acquisition of "Ai-Pro Co., Ltd.," a smartphone repair business operating 36 stores nationwide.
(2026/07/01) Having also announced the acquisition of shares (49% of voting rights) in "Next Security Co., Ltd." the previous day, the stock is being flooded with buy orders due to speculation regarding business portfolio expansion and earnings transformation through two consecutive days of M&A.
#ReYuuJapan #ReuseSmartphone #M&A #SubsidiaryAcquisition
4th Place: JN Group (6634, TSE Standard)
[Business Description]
Formerly J-Next. Develops audio/visual equipment and operates amusement (pachinko/pachislot) related peripherals and system development.
[Reason for Rise]
While no specific new material is apparent, as it is a low-priced stock in the double digits (80 yen range), it appears that short-term capital inflows have accelerated, attracted by the ease of price movement.
[Related News]
(2026/07/01) Reached the effective date for the absorption-type merger of its wholly-owned subsidiary "Nexfarm Holdings Co., Ltd." and completed post-merger disclosure. Efficiency gains are expected through the consolidation of management resources.
(2026/03/01) Changed trade name from former Nex Group to "JN Group." Amidst a structural shift toward Web3, crypto assets, and IoT solutions, the stock saw a sudden rebound today.
#JNGroup #LowPricedStock #AbsorptionMerger #StructuralShift
5th Place: Infomart (2492, TSE Prime)
[Business Description]
Operates B2B electronic commerce platforms, primarily for the food industry. Boasts an overwhelming market share in the digitization of invoices and purchase orders.
[Reason for Rise]
A Prime Market stock. Earnings recovery trends and bargain hunting from the bottom range have pushed the stock price up, with large-scale buying including mid-to-long-term investors.
[Related News]
(2026/06/29) Passed the ex-dividend and shareholder benefit date at the end of June. Having cleared the supply-demand event, the stock moved to strengthen its recovery trend after a sense of selling exhaustion.
(2026/02/13) Announced a significant profit increase forecast for the fiscal year ending December 2026, with consolidated operating profit reaching 5 billion yen (a 74.6% increase year-on-year). The growth trajectory of the B2B electronic invoicing platform is supporting the downside.
#Infomart #B2BPlatform #ElectronicInvoicing #SignificantProfitIncrease
6th Place: Toshin HD (9444, TSE Standard)
[Business Description]
Primarily operates mobile phone sales agencies (shop management) while also engaging in diversified businesses such as golf course management and real estate.
[Reason for Rise]
In addition to individual bargain hunting focused on solid earnings and dividend/shareholder benefit yields, the stock trended upward due to a temporary improvement in supply and demand.
[Related News]
(2026/06/12) Disclosures regarding legal reorganization procedures and management rights, such as an immediate appeal against the decision to commence corporate reorganization proceedings, have been occurring in succession.
(2026/05/28) At an extraordinary general meeting of shareholders, proposals for the dismissal of the former representative director and the election of new directors were passed. Intense price volatility continues due to complex supply-demand speculation following the progress of the reorganization scheme and fundamental governance renewal under the trustee system.
#ToshinHD #MobileSalesAgency #GovernanceRenewal #SpeculativeStock
7th Place: Innovacell (504A, TSE Growth)
[Business Description]
A bio-venture company engaged in the research and development of regenerative medicine products using stem cells derived from skeletal muscle. Targets include the treatment of urinary incontinence.
[Reason for Rise]
Possessing the characteristics of a recent IPO, short-term capital from day traders and others flowed in due to the ease of price movement. Growing interest in the biotech sector also served as a tailwind.
[Related News]
(2026/07/03) Timely disclosure was made regarding the international joint Phase 3 clinical trial for the urgent fecal incontinence treatment drug "ICEF15," stating that approval for patient enrollment in the U.S. has been obtained. This news was viewed positively, leading to a stop-high buy order.
(2026/02/12) Newly listed on the TSE Growth Market (IPO). Although the stock had been trending downward since its listing, this major catalyst—the advancement of the Phase 3 trial in the U.S.—marks a turning point that has significantly shifted the tide for the stock price.
#InnovaCell #RegenerativeMedicine #ClinicalTrialProgress #StopHigh
8th Place: CANBAS (4575, TSE Growth)
[Business Description]
A drug discovery biotech venture specializing in the research and development of anti-cancer drugs. It promotes the drug discovery process from the initial stages through to clinical trials.
[Reason for Rise]
Driven by the sharp rise of Kubota Pharmaceutical Holdings in 1st place, speculative buying (sector rotation) spread to the entire biotech venture sector, resulting in a significant gain.
[Related News]
(2026/06/30) Announced the full-year consolidated earnings forecast for the fiscal year ending June 2026, which had previously been undisclosed. Due to increased development costs associated with preparations for Phase 3 clinical trials in Europe, a final deficit of 1.22 billion yen is expected. However, this was viewed as a positive expense recognition accompanying development progress, attracting buying interest as the news was already priced in (selling exhaustion).
(2026/05/14) In the third-quarter financial results, the company suggested the continuation of partnership negotiations with major pharmaceutical companies and steady progress in its pipeline. Following a period of speculation-driven movement, today saw a sharp rebound involving short covering.
#CANBAS #DrugDiscoveryVenture #AntiCancerDrug #SellingExhaustion
9th Place: Liberta (4935, TSE Standard)
[Business Description]
A fabless company engaged in the planning and sales of daily sundries, cosmetics, and functional clothing. Known for hit products such as "Baby Foot."
[Reason for Rise]
Speculative buying fueled by new product announcements and social media buzz, along with short covering supported by light supply and demand, bolstered the rise.
[Related News]
(2026/07/02) Announced the start of pre-sales for the new "LaLuna Air Eye Mask" on the pre-order platform "Makuake." Diversification of the product portfolio is being noted.
(2026/06/18) Announced the national TV commercial broadcast and promotion strengthening for its flagship product, the functional cooling wear "Freeze Tech." Ahead of the arrival of intense summer heat, the stock was favored not only for its theme as a "heat stroke countermeasure stock" but also for its financial stability following the renewal of its commitment line.
#Liberta #FablessCompany #HeatStrokeCountermeasureStock #Makuake
10th Place: Nakamura Choukou (6166, TSE Growth)
[Business Description]
Development and manufacturing of special tools such as diamond wires. In recent years, the company has also focused on material businesses in environmental and advanced technology fields, such as nanoparticle manufacturing equipment and zeolite-related products.
[Reason for Rise]
Speculative buying related to advanced technology and new materials continues, and the stock is showing a strong upward trend with significant volume, eyeing the 1,000 yen milestone.
[Related News]
(2026/06/26) After the market closed, announced the start of "joint research on recovery technology for dilute rare earth ions" and "matters concerning business plans and growth potential." This came as a surprise, as it is a material directly linked to a national policy theme of extreme interest regarding economic security.
(2026/05/15) Announced consolidated financial results for the fiscal year ended March 2026. Although current performance fell into an operating deficit, the new medium-term management plan clearly stated a structural reform through a shift to new energy and material fields such as nano-sized zeolite, with a target of returning to profitability by the fiscal year ending March 2029. With short-term negative factors now priced in, the release of rare earth material news has created a powerful short-squeeze market.
#NakamuraChoukou #SpecialTools #RareEarth #JointResearch
💡 3. Points of interest from the ranking
Looking at today's ranking as a whole, while stocks that announced "clear individual materials (M&A or milestone achievements)" are being bought straightforwardly, it is evident that very strong capital is flowing into "ultra-low-priced stocks/rebound targets" with stock prices in the double digits to low triple digits.
With large-cap stocks taking a breather, the appetite for selection among individual investors has not waned; rather, the impression is that they have shifted their targets to "light stocks where price range gains can be expected."
Disclaimer: This article is for informational purposes only and does not recommend the buying or selling of any specific stock. Please make final investment decisions based on your own judgment and responsibility.
